Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Expert Review of Cardiovascular Therapy|December 22, 2007
The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular diseaseCharles H Hennekens, Wendy R SchneiderJournal of General Internal Medicine|September 23, 2009
Use of aspirin among diabetics in the primary prevention of cardiovascular disease: need for reliable randomized evidence and astute clinical judgmentPatricia R Hebert, Wendy R Schneider, Charles H HennekensJournal of Cardiovascular Pharmacology and Therapeutics|April 3, 2009
Modest dietary reductions in blood cholesterol have important public health benefitsCharles H Hennekens, Wendy R Schneider, E Joan Barice, et al.The Journal of Family Practice|April 9, 2008
Lumbar spinal stenosis: can positional therapy alleviate pain?Stuart M Goldman, E Joan Barice, Wendy R Schneider, et al.Journal of Cardiovascular Pharmacology and Therapeutics|January 4, 2011
The need for increased utilization of statins after occlusive strokePatricia R Hebert, Denis Evans, Wendy R Schneider, et al.Ethnicity & Disease|August 9, 2007
Guidelines for management of high-risk African Americans with multiple cardiovascular risk factors: recommendations of an expert consensus panelRichard Allen Williams, John M Flack, James R Gavin, et al.American Heart Journal|May 4, 2010
Hypothesis formulation from subgroup analyses: nonadherence or nonsteroidal anti-inflammatory drug use explains the lack of clinical benefit of aspirin on first myocardial infarction attributed to "aspirin resistance"Charles H Hennekens, Wendy R Schneider, Patricia R Hebert, et al.Journal of General Internal Medicine|October 6, 2010
Control of health care-associated infections (HAI): winning both the battles and the warN Joel Ehrenkranz, Ann T MacIntyre, Patricia R Hebert, et al.Journal of Cardiovascular Pharmacology and Therapeutics|October 13, 2010
A randomized trial of aspirin at clinically relevant doses and nitric oxide formation in humansCharles H Hennekens, Wendy R Schneider, Alex Pokov, et al.Contemporary Clinical Trials|July 6, 2010
Academic perspectives on the United States Food and Drug Administration's guidance for industry on diabetes mellitusCharles H Hennekens, Patricia R Hebert, Wendy R Schneider, et al.Pageof 1